▶ 調査レポート

転移性黒色腫薬市場:世界及び中国市場分析・予測(~2024年)

• 英文タイトル:Metastatic Melanoma Drug Market Insights 2019, Global and Chinese Analysis and Forecast to 2024

Prof Researchが調査・発行した産業分析レポートです。転移性黒色腫薬市場:世界及び中国市場分析・予測(~2024年) / Metastatic Melanoma Drug Market Insights 2019, Global and Chinese Analysis and Forecast to 2024 / C9OT4225資料のイメージです。• レポートコード:C9OT4225
• 出版社/出版日:Prof Research / 2019年10月8日
※2024年版があります。お問い合わせください。

• レポート形態:英文、PDF、138ページ
• 納品方法:Eメール(受注後2-3営業日)
• 産業分類:医療・バイオ
• 販売価格(消費税別)
  Single User¥444,000 (USD3,000)▷ お問い合わせ
  Site License¥562,400 (USD3,800)▷ お問い合わせ
  Global Site License¥740,000 (USD5,000)▷ お問い合わせ
• ご注文方法:お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法:銀行振込(納品後、ご請求書送付)
レポート概要
「転移性黒色腫薬市場:世界及び中国市場分析・予測(~2024年)」は、世界及び中国における転移性黒色腫薬市場について調査・分析したレポートで、転移性黒色腫薬の世界市場動向、市場規模、主要企業情報などが含まれています。転移性黒色腫薬のタイプ別には、AGI-134、ALT-801、ALT-803、AMG-232、その他に分けて分析し、地域別には、アメリカ、ヨーロッパ、日本、中国などに区分してまとめてあります。
・転移性黒色腫薬産業の概要
・転移性黒色腫薬の製造技術分析
・主要企業分析:企業概要、製品情報、連絡先など
・世界及び中国の転移性黒色腫薬市場 2014年-2019年
・世界及び中国の転移性黒色腫薬市場現状
・企業別分析:Merck& Co., Inc., Merck KGaA, Millennium Pharmaceuticals, Inc., Morphotek, Inc., NewLink Genetics Corporation, Novartis AG, Omeros Corporation, Oncolytics Biotech Inc., OncoSec Medical Inc., Ono Pharmなど
・地域別分析:アメリカ、ヨーロッパ、日本、中国など
・タイプ別分析:AGI-134、ALT-801、ALT-803、AMG-232、その他
・世界及び中国の転移性黒色腫薬市場予測 2019年-2024年
・転移性黒色腫薬の産業チェーン分析
・世界及び中国のマクロ経済動向と影響
・世界及び中国の転移性黒色腫薬市場動向・課題・機会
・新規プロジェクトへの提言・結論

Metastatic Melanoma Drug Market Insights 2019, Global and Chinese Scenario is a professional and in-depth study on the current state of the global Metastatic Melanoma Drug industry with a focus on the Chinese market. The report provides key statistics on the market status of the Metastatic Melanoma Drug manufacturers and is a valuable source of guidance and direction for companies and individuals interested in the industry.Overall, the report provides an in-depth insight of 2014-2024 global and Chinese Metastatic Melanoma Drug market covering all important parameters.

The key ponits of the report:
1.The report provides a basic overview of the industry including its definition, applications and manufacturing technology.
2.The report explores the international and Chinese major industry players in detail. In this part, the report presents the company profile, product specifications, capacity, production value, and 2014-2019 market shares for each company.
3.Through the statistical analysis, the report depicts the global and Chinese total market of Metastatic Melanoma Drug industry including capacity, production, production value, cost/profit, supply/demand and Chinese import/export.
4.The total market is further divided by company, by country, and by application/type for the competitive landscape analysis.
5.The report then estimates 2019-2024 market development trends of Metastatic Melanoma Drug industry. Analysis of upstream raw materials, downstream demand, and current market dynamics is also carried out.
6.The report makes some important proposals for a new project of Metastatic Melanoma Drug Industry before evaluating its feasibility.

There are 3 key segments covered in this report: competitor segment, product type segment, end use/application segment.

For competitor segment, the report includes global key players of Metastatic Melanoma Drug as well as some small players. At least 10 companies are included:
* Merck& Co.
* Merck KGaA
* Millennium Pharmaceuticals
* Morphotek
* NewLink Genetics Corporation
* Novartis AG
For complete companies list, please ask for sample pages.

The information for each competitor includes:
* Company Profile
* Main Business Information
* SWOT Analysis
* Sales, Revenue, Price and Gross Margin
* Market Share

For product type segment, this report listed main product type of Metastatic Melanoma Drug market in gloabal and china.
* AGI-134
* ALT-801
* ALT-803
* AMG-232
* Others

For end use/application segment, this report focuses on the status and outlook for key applications. End users sre also listed.
* Hospital
* Clinic
* Others

Reasons to Purchase this Report:

* Estimates 2019-2024 Metastatic Melanoma Drug market development trends with the recent trends and SWOT analysis
* Market dynamics scenario, along with growth opportunities of the market in the years to come
* Market segmentation analysis including qualitative and quantitative research incorporating the impact of economic and policy aspects
* Regional and country level analysis integrating the demand and supply forces that are influencing the growth of the market.
* Market value (USD Million) and volume (Units Million) data for each segment and sub-segment
* Competitive landscape involving the market share of major players, along with the new projects and strategies adopted by players in the past five years
* Comprehensive company profiles covering the product offerings, key financial information, recent developments, SWOT analysis, and strategies employed by the major market players
* 1-year analyst support, along with the data support in excel format.

Any special requirements about this report, please let us know and we can provide custom report.

レポート目次

Chapter One Introduction of Metastatic Melanoma Drug Industry
1.1 Brief Introduction of Metastatic Melanoma Drug
1.2 Development of Metastatic Melanoma Drug Industry
1.3 Status of Metastatic Melanoma Drug Industry

Chapter Two Manufacturing Technology of Metastatic Melanoma Drug
2.1 Development of Metastatic Melanoma Drug Manufacturing Technology
2.2 Analysis of Metastatic Melanoma Drug Manufacturing Technology
2.3 Trends of Metastatic Melanoma Drug Manufacturing Technology

Chapter Three Analysis of Global Key Manufacturers
3.1 Merck& Co.
3.1.1 Company Profile
3.1.2 Product Information
3.1.3 2014-2019 Production Information
3.1.4 Contact Information
3.2 Merck KGaA
3.2.1 Company Profile
3.2.2 Product Information
3.2.3 2014-2019 Production Information
3.2.4 Contact Information
3.3 Millennium Pharmaceuticals
3.2.1 Company Profile
3.3.2 Product Information
3.3.3 2014-2019 Production Information
3.3.4 Contact Information
3.4 Morphotek
3.4.1 Company Profile
3.4.2 Product Information
3.4.3 2014-2019 Production Information
3.4.4 Contact Information
3.5 NewLink Genetics Corporation
3.5.1 Company Profile
3.5.2 Product Information
3.5.3 2014-2019 Production Information
3.5.4 Contact Information
3.6 Novartis AG
3.6.1 Company Profile
3.6.2 Product Information
3.5.3 2014-2019 Production Information
3.6.4 Contact Information
3.7 Omeros Corporation
3.7.1 Company Profile
3.7.2 Product Information
3.7.3 2014-2019 Production Information
3.7.4 Contact Information
3.8 Company H
3.8.1 Company Profile
3.8.2 Product Information
3.8.3 2014-2019 Production Information
3.8.4 Contact Information
……
……

Chapter Four 2014-2019 Global and Chinese Market of Metastatic Melanoma Drug
4.1 2014-2019 Global Capacity, Production and Production Value of Metastatic Melanoma Drug Industry
4.2 2014-2019 Global Cost and Profit of Metastatic Melanoma Drug Industry
4.3 Market Comparison of Global and Chinese Metastatic Melanoma Drug Industry
4.4 2014-2019 Global and Chinese Supply and Consumption of Metastatic Melanoma Drug
4.5 2014-2019 Chinese Import and Export of Metastatic Melanoma Drug

Chapter Five Market Status of Metastatic Melanoma Drug Industry
5.1 Market Competition of Metastatic Melanoma Drug Industry by Company
5.2 Market Competition of Metastatic Melanoma Drug Industry by Country (USA, EU, Japan, Chinese etc.)
5.3 Market Analysis of Metastatic Melanoma Drug Consumption by Application/Type

Chapter Six 2019-2024 Market Forecast of Global and Chinese Metastatic Melanoma Drug Industry
6.1 2019-2024 Global and Chinese Capacity, Production, and Production Value of Metastatic Melanoma Drug
6.2 2019-2024 Metastatic Melanoma Drug Industry Cost and Profit Estimation
6.3 2019-2024 Global and Chinese Market Share of Metastatic Melanoma Drug
6.4 2019-2024 Global and Chinese Supply and Consumption of Metastatic Melanoma Drug
6.5 2019-2024 Chinese Import and Export of Metastatic Melanoma Drug

Chapter Seven Analysis of Metastatic Melanoma Drug Industry Chain
7.1 Industry Chain Structure
7.2 Upstream Raw Materials
7.3 Downstream Industry

Chapter Eight Global and Chinese Economic Impact on Metastatic Melanoma Drug Industry
8.1 Global and Chinese Macroeconomic Environment Analysis
8.1.1 Global Macroeconomic Analysis
8.1.2 Chinese Macroeconomic Analysis
8.2 Global and Chinese Macroeconomic Environment Development Trend
8.2.1 Global Macroeconomic Outlook
8.2.2 Chinese Macroeconomic Outlook
8.3 Effects to Metastatic Melanoma Drug Industry

Chapter Nine Market Dynamics of Metastatic Melanoma Drug Industry
9.1 Metastatic Melanoma Drug Industry News
9.2 Metastatic Melanoma Drug Industry Development Challenges
9.3 Metastatic Melanoma Drug Industry Development Opportunities

Chapter Ten Proposals for New Project
10.1 Market Entry Strategies
10.2 Countermeasures of Economic Impact
10.3 Marketing Channels
10.4 Feasibility Studies of New Project Investment

Chapter Eleven Research Conclusions of Global and Chinese Metastatic Melanoma Drug Industry

Tables and Figures
Figure Metastatic Melanoma Drug Product Picture
Table Development of Metastatic Melanoma Drug Manufacturing Technology
Figure Manufacturing Process of Metastatic Melanoma Drug
Table Trends of Metastatic Melanoma Drug Manufacturing Technology
Figure Metastatic Melanoma Drug Product and Specifications
Table 2014-2019 Metastatic Melanoma Drug Product Capacity, Production, and Production Value etc. List
Figure 2014-2019 Metastatic Melanoma Drug Capacity Production and Growth Rate
Figure 2014-2019 Metastatic Melanoma Drug Production Global Market Share
Figure Metastatic Melanoma Drug Product and Specifications
Table 2014-2019 Metastatic Melanoma Drug Product Capacity, Production, and Production Value etc. List
Figure 2014-2019 Metastatic Melanoma Drug Capacity Production and Growth Rate
Figure 2014-2019 Metastatic Melanoma Drug Production Global Market Share
Figure Metastatic Melanoma Drug Product and Specifications
Table 2014-2019 Metastatic Melanoma Drug Product Capacity Production Price Cost Production Value List
Figure 2014-2019 Metastatic Melanoma Drug Capacity Production and Growth Rate
Figure 2014-2019 Metastatic Melanoma Drug Production Global Market Share
Figure Metastatic Melanoma Drug Product and Specifications
Table 2014-2019 Metastatic Melanoma Drug Product Capacity, Production, and Production Value etc. List
Figure 2014-2019 Metastatic Melanoma Drug Capacity Production and Growth Rate
Figure 2014-2019 Metastatic Melanoma Drug Production Global Market Share
Figure Metastatic Melanoma Drug Product and Specifications
Table 2014-2019 Metastatic Melanoma Drug Product Capacity Production Price Cost Production Value List
Figure 2014-2019 Metastatic Melanoma Drug Capacity Production and Growth Rate
Figure 2014-2019 Metastatic Melanoma Drug Production Global Market Share
Figure Metastatic Melanoma Drug Product and Specifications
Table 2014-2019 Metastatic Melanoma Drug Product Capacity, Production, and Production Value etc. List
Figure 2014-2019 Metastatic Melanoma Drug Capacity Production and Growth Rate
Figure 2014-2019 Metastatic Melanoma Drug Production Global Market Share
Figure Metastatic Melanoma Drug Product and Specifications
Table 2014-2019 Metastatic Melanoma Drug Product Capacity, Production, and Production Value etc. List
Figure 2014-2019 Metastatic Melanoma Drug Capacity Production and Growth Rate
Figure 2014-2019 Metastatic Melanoma Drug Production Global Market Share
Figure Metastatic Melanoma Drug Product and Specifications
Table 2014-2019 Metastatic Melanoma Drug Product Capacity, Production, and Production Value etc. List
Figure 2014-2019 Metastatic Melanoma Drug Capacity Production and Growth Rate
Figure 2014-2019 Metastatic Melanoma Drug Production Global Market Share
……
……
Table 2014-2019 Global Metastatic Melanoma Drug Capacity List
Table 2014-2019 Global Metastatic Melanoma Drug Key Manufacturers Capacity Share List
Figure 2014-2019 Global Metastatic Melanoma Drug Manufacturers Capacity Share
Table 2014-2019 Global Metastatic Melanoma Drug Key Manufacturers Production List
Table 2014-2019 Global Metastatic Melanoma Drug Key Manufacturers Production Share List
Figure 2014-2019 Global Metastatic Melanoma Drug Manufacturers Production Share
Figure 2014-2019 Global Metastatic Melanoma Drug Capacity Production and Growth Rate
Table 2014-2019 Global Metastatic Melanoma Drug Key Manufacturers Production Value List
Figure 2014-2019 Global Metastatic Melanoma Drug Production Value and Growth Rate
Table 2014-2019 Global Metastatic Melanoma Drug Key Manufacturers Production Value Share List
Figure 2014-2019 Global Metastatic Melanoma Drug Manufacturers Production Value Share
Table 2014-2019 Global Metastatic Melanoma Drug Capacity Production Cost Profit and Gross Margin List
Figure 2014-2019 Chinese Share of Global Metastatic Melanoma Drug Production
Table 2014-2019 Global Supply and Consumption of Metastatic Melanoma Drug
Table 2014-2019 Import and Export of Metastatic Melanoma Drug
Figure 2018 Global Metastatic Melanoma Drug Key Manufacturers Capacity Market Share
Figure 2018 Global Metastatic Melanoma Drug Key Manufacturers Production Market Share
Figure 2018 Global Metastatic Melanoma Drug Key Manufacturers Production Value Market Share
Table 2014-2019 Global Metastatic Melanoma Drug Key Countries Capacity List
Figure 2014-2019 Global Metastatic Melanoma Drug Key Countries Capacity
Table 2014-2019 Global Metastatic Melanoma Drug Key Countries Capacity Share List
Figure 2014-2019 Global Metastatic Melanoma Drug Key Countries Capacity Share
Table 2014-2019 Global Metastatic Melanoma Drug Key Countries Production List
Figure 2014-2019 Global Metastatic Melanoma Drug Key Countries Production
Table 2014-2019 Global Metastatic Melanoma Drug Key Countries Production Share List
Figure 2014-2019 Global Metastatic Melanoma Drug Key Countries Production Share
Table 2014-2019 Global Metastatic Melanoma Drug Key Countries Consumption Volume List
Figure 2014-2019 Global Metastatic Melanoma Drug Key Countries Consumption Volume
Table 2014-2019 Global Metastatic Melanoma Drug Key Countries Consumption Volume Share List
Figure 2014-2019 Global Metastatic Melanoma Drug Key Countries Consumption Volume Share
Figure 78 2014-2019 Global Metastatic Melanoma Drug Consumption Volume Market by Application
Table 89 2014-2019 Global Metastatic Melanoma Drug Consumption Volume Market Share List by Application
Figure 79 2014-2019 Global Metastatic Melanoma Drug Consumption Volume Market Share by Application
Table 90 2014-2019 Chinese Metastatic Melanoma Drug Consumption Volume Market List by Application
Figure 80 2014-2019 Chinese Metastatic Melanoma Drug Consumption Volume Market by Application
Figure 2019-2024 Global Metastatic Melanoma Drug Capacity Production and Growth Rate
Figure 2019-2024 Global Metastatic Melanoma Drug Production Value and Growth Rate
Table 2019-2024 Global Metastatic Melanoma Drug Capacity Production Cost Profit and Gross Margin List
Figure 2019-2024 Chinese Share of Global Metastatic Melanoma Drug Production
Table 2019-2024 Global Supply and Consumption of Metastatic Melanoma Drug
Table 2019-2024 Import and Export of Metastatic Melanoma Drug
Figure Industry Chain Structure of Metastatic Melanoma Drug Industry
Figure Production Cost Analysis of Metastatic Melanoma Drug
Figure Downstream Analysis of Metastatic Melanoma Drug
Table Growth of World output, 2014 – 2019, Annual Percentage Change
Figure Unemployment Rates in Selected Developed Countries, January 2014 – March 2018
Figure Nominal Effective Exchange Rate: Japan and Selected Emerging Economies, September 2014-March 2018
Figure 2014-2019 Chinese GDP and Growth Rates
Figure 2014-2019 Chinese CPI Changes
Figure 2014-2019 Chinese PMI Changes
Figure 2014-2019 Chinese Financial Revenue and Growth Rate
Figure 2014-2019 Chinese Total Fixed Asset Investment and Growth Rate
Figure 2019-2024 Chinese GDP and Growth Rates
Figure 2019-2024 Chinese CPI Changes
Table Economic Effects to Metastatic Melanoma Drug Industry
Table Metastatic Melanoma Drug Industry Development Challenges
Table Metastatic Melanoma Drug Industry Development Opportunities
Figure Map of Chinese 33 Provinces and Administrative Regions
Table Selected Cities According to Industrial Orientation
Figure Chinese IPR Strategy
Table Brief Summary of Suggestions
Table New Metastatic Melanoma Drugs Project Feasibility Study